300685 Stock Overview
Amoy Diagnostics Co., Ltd. develops and sells molecular diagnostics for oncology precision medicine in China and internationally.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Amoy Diagnostics Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥21.37 |
52 Week High | CN¥30.39 |
52 Week Low | CN¥14.60 |
Beta | 0.62 |
1 Month Change | 4.09% |
3 Month Change | -0.65% |
1 Year Change | -22.12% |
3 Year Change | -46.08% |
5 Year Change | 7.19% |
Change since IPO | 420.33% |
Recent News & Updates
What Amoy Diagnostics Co., Ltd.'s (SZSE:300685) 33% Share Price Gain Is Not Telling You
Mar 02Is Amoy Diagnostics Co., Ltd. (SZSE:300685) Worth CN¥22.0 Based On Its Intrinsic Value?
Mar 01Shareholder Returns
300685 | CN Biotechs | CN Market | |
---|---|---|---|
7D | -7.8% | -4.9% | -2.2% |
1Y | -22.1% | -20.7% | -14.8% |
Return vs Industry: 300685 underperformed the CN Biotechs industry which returned -20.7% over the past year.
Return vs Market: 300685 underperformed the CN Market which returned -14.8% over the past year.
Price Volatility
300685 volatility | |
---|---|
300685 Average Weekly Movement | 8.1% |
Biotechs Industry Average Movement | 8.0% |
Market Average Movement | 8.1% |
10% most volatile stocks in CN Market | 11.4% |
10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 300685's share price has been volatile over the past 3 months.
Volatility Over Time: 300685's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2008 | 1,101 | Jiemin Luo | https://www.amoydx.com |
Amoy Diagnostics Co., Ltd. develops and sells molecular diagnostics for oncology precision medicine in China and internationally. The company offers NGS, real-time PCR, FISH, and extraction assays. Amoy Diagnostics Co., Ltd.
Amoy Diagnostics Co., Ltd. Fundamentals Summary
300685 fundamental statistics | |
---|---|
Market cap | CN¥8.66b |
Earnings (TTM) | CN¥213.32m |
Revenue (TTM) | CN¥950.51m |
39.5x
P/E Ratio8.9x
P/S RatioIs 300685 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300685 income statement (TTM) | |
---|---|
Revenue | CN¥950.51m |
Cost of Revenue | CN¥169.04m |
Gross Profit | CN¥781.47m |
Other Expenses | CN¥568.15m |
Earnings | CN¥213.32m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 16, 2024
Earnings per share (EPS) | 0.54 |
Gross Margin | 82.22% |
Net Profit Margin | 22.44% |
Debt/Equity Ratio | 3.1% |
How did 300685 perform over the long term?
See historical performance and comparison